IRIS
IEZZI, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.443
AS - Asia 4.801
EU - Europa 4.745
SA - Sud America 658
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 10
Totale 17.768
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.293
SG - Singapore 1.944
CN - Cina 1.249
IT - Italia 893
IE - Irlanda 713
UA - Ucraina 610
BR - Brasile 540
RU - Federazione Russa 504
SE - Svezia 494
TR - Turchia 494
VN - Vietnam 464
GB - Regno Unito 448
DE - Germania 343
IN - India 330
FR - Francia 294
FI - Finlandia 162
CA - Canada 81
HK - Hong Kong 74
NL - Olanda 63
AR - Argentina 48
PL - Polonia 47
ZA - Sudafrica 42
MX - Messico 40
CZ - Repubblica Ceca 39
BD - Bangladesh 34
BE - Belgio 32
IQ - Iraq 32
ES - Italia 25
JP - Giappone 25
AT - Austria 24
KR - Corea 20
VE - Venezuela 18
IR - Iran 16
PK - Pakistan 15
SA - Arabia Saudita 15
EC - Ecuador 14
MA - Marocco 13
CO - Colombia 12
EU - Europa 12
ID - Indonesia 11
IL - Israele 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
RO - Romania 10
CH - Svizzera 9
CL - Cile 8
EG - Egitto 8
GR - Grecia 8
AU - Australia 7
JM - Giamaica 7
MY - Malesia 7
OM - Oman 7
PH - Filippine 7
BG - Bulgaria 6
PY - Paraguay 6
TN - Tunisia 6
UZ - Uzbekistan 6
LT - Lituania 5
PE - Perù 5
PT - Portogallo 5
UY - Uruguay 5
AO - Angola 4
AZ - Azerbaigian 4
BZ - Belize 4
HN - Honduras 4
JO - Giordania 4
KZ - Kazakistan 4
NP - Nepal 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
ET - Etiopia 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
DZ - Algeria 2
LA - Repubblica Popolare Democratica del Laos 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
Totale 17.762
Salva come PNG Salva come JPEG
Città #
Singapore 1.461
Chandler 896
San Jose 895
Jacksonville 704
Dublin 703
Ashburn 486
Beijing 354
Dallas 300
Princeton 300
Southend 286
Dearborn 233
Izmir 225
Nanjing 188
New York 181
Santa Clara 158
Council Bluffs 157
Ann Arbor 156
Los Angeles 154
Ho Chi Minh City 150
Altamura 134
Wilmington 134
Chieti 126
The Dalles 112
Cambridge 111
Pescara 102
Boardman 98
Hanoi 91
Tongling 78
Hong Kong 68
Buffalo 66
São Paulo 64
Nanchang 63
Munich 62
Moscow 56
Redondo Beach 56
Woodbridge 50
Orem 41
Warsaw 39
Brooklyn 37
Denver 37
Helsinki 36
Montreal 35
Hebei 34
Grevenbroich 33
Johannesburg 33
Tianjin 32
Washington 32
Chennai 31
Dong Ket 31
Nuremberg 31
Rome 31
Frankfurt am Main 30
Seattle 29
Shenyang 29
Brno 28
Atlanta 27
London 27
Milan 27
Chicago 26
Hefei 26
Houston 26
Amsterdam 24
Brussels 24
Kunming 24
Tokyo 24
Norwalk 23
Ancona 21
Changsha 21
Haiphong 20
Mexico City 20
Poplar 20
Seoul 20
Ankara 19
Augusta 19
Da Nang 19
Turku 19
Hangzhou 18
Jiaxing 18
Rio de Janeiro 18
Toronto 18
Manchester 17
Stockholm 17
Baghdad 16
Boston 16
Castignano 16
Jinan 16
San Mateo 16
Mumbai 15
Vienna 15
Lappeenranta 14
Orange 14
Phoenix 14
Pune 14
Falls Church 13
Guangzhou 13
San Francisco 13
St Louis 13
Belo Horizonte 12
Biên Hòa 12
Camerino 12
Totale 10.923
Salva come PNG Salva come JPEG
Nome #
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 213
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 199
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 182
L’allergoide monomerico agisce anche sul GALT 177
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 172
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 172
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 169
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 165
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 165
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 162
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 158
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 158
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 157
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 156
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 156
Anti-Thyroid Effect of Resveratrol 154
Resveratrol has anti-thyroid effects both in vitro and in vivo 154
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 153
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 152
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 150
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 150
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 147
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 146
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 143
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 142
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. 141
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 141
Effects of chronic hypoxia and cobalt on macroprotein pattern in the rabbit carotid body and superior cervical ganglion: preliminary observations. 140
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 139
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 139
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 138
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 138
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 137
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 137
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 137
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 135
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer. 133
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 133
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 132
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 132
EFFECTS OF HYPERBARIC OXYGEN EXPOSURE ON MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS 132
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 132
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 132
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 131
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 131
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 131
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 131
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. 130
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 129
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 129
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 129
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 129
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 128
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 127
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 126
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 126
null 125
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 124
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer 124
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 123
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 123
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 123
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 122
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 121
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 120
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 120
Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. 119
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 119
Expression of CREB in Primary Pterygium and Correlation with Cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. 119
Antimetastatic activity of a preventive cancer vaccine. 118
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 118
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 118
Neutrophils in anti-cancer immunological strategies: old players in new games 117
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 116
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 115
p130Cas is an essential transducer element in ErbB2 transformation. 115
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 115
Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. 115
Stem Cell Emergence After HBO In Volunteers 114
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDAapproved compounds 113
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 112
rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant. 112
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 112
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 112
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 111
Effect of acute and chronic cobalt administration on carotid body chemoreceptors responses. 111
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 111
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 110
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 110
Generation of multiparametric MRI maps by using Gd-labelled-RBCs reveals phenotypes and stages of murine prostate cancer 110
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 109
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. 109
Arginase 1-based immune modulatory vaccines induce anti-cancer immunity and synergize with anti-PD-1 checkpoint blockade 109
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 108
Phospholipase Cgamma1 is required for metastasis development and progression 108
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 107
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 106
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 106
Multiorgan Metastasis of Human HER-2(+) Breast Cancer in Rag2(-/-);Il2rg(-/-) Mice and Treatment with PI3K Inhibitor. 105
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 103
Totale 13.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 0 65
2021/2022708 14 14 14 120 53 12 26 60 55 50 83 207
2022/20232.468 184 362 156 280 272 471 127 168 285 32 63 68
2023/20241.158 78 54 68 51 61 346 270 66 14 28 13 109
2024/20252.929 173 490 388 102 94 136 205 194 294 130 325 398
2025/20266.196 491 257 574 786 651 416 1.077 360 656 542 268 118
Totale 18.339